A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist
NCT ID NCT04687475
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This trial tests whether a home monitoring tool — combining daily lung function measurements and symptom surveys — can help doctors better manage cystic fibrosis patients who are waiting for a lung transplant. The tool sends data to the clinic, which may trigger earlier adjustments to a patient's priority score for transplant. Ten adults with cystic fibrosis who are already listed for a lung transplant will use the tool and be followed to see if it improves their chances of getting a transplant in time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a clinical tool combining home spirometry and symptom surveys
- What this could lead to
- If it works, this tool could help doctors prioritize lung transplants for cystic fibrosis patients who need them most, potentially reducing deaths while on the waiting list.
- What could go wrong
- This is a very small pilot study with only 10 participants, so results may not apply broadly. The tool depends on patients having and using a home spirometer, which may limit its use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
10 people
The number who actually took part.
- Started
-
Apr 2020
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of Cystic Fibrosis * To be listed for lung transplant * Has purchased home spirometer Exclusion Criteria: * Diagnosis other than Cystic Fibrosis * Unable to read * Unable to use computer or smartphone device to access mobile application
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cystic fibrosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Device-Preserved donor lungs boost transplant success?
- Can a simple questionnaire reveal why some cystic fibrosis patients skip physiotherapy?
- Cystic fibrosis diabetes: do gut hormones and genes hold the key?
- Can a special lung scan catch cystic fibrosis damage earlier than standard tests?
- Can a pill replace the liquid? testing a new form of cystic fibrosis drug
- Triple therapy under the microscope: does it transform cystic fibrosis care?